Tovetumab (MEDI-575) is an anti-PDGFRalpha monoclonal antibody that selectively blocks the PDGFRalpha signal transduction. Tovetumab can be used in the research of glioblastoma and non-small cell lung cancer (NSCLC).
Purity:
99.0%
CAS Number:
[1243266-04-7]
Target:
VEGFR/PDGFR
* VAT and and shipping costs not included. Errors and price changes excepted